The data would agree with a protective effect of LPAR2 antagonism in the context of stress-evoked depression and age-associated restlessness, which are typical findings in conditions related to hippocampal hyperexcitability upon normal aging [20] or in neurodegenerative disorders such as Alzheimer's disease [57]. Here, LPAR2 is linked to early-onset autosomal dominant Alzheimer disease.